ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

June Panel Meeting Dropped

June 3, 1977

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed

November 26, 1999

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990